In the early development of atherosclerosis, adiponectin has been demonstrated to inhibit monocyte-macrophage migration, thus reducing the attachment of monocytes to injured endothelial cells and the formation of macrophage foam cells (37, 38). The gene discussed is ADIPOQ; the disease is atherosclerosis.